SEC Filing Summary: Midatech Pharma PLC (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Midatech Pharma PLC, a foreign private issuer, for the month of December 2022. The filing date is December 15, 2022. The registrant is headquartered in Cardiff, United Kingdom. Note: The request metadata references "Biodexa Pharmaceuticals Plc," but the filing text explicitly identifies the registrant as "Midatech Pharma PLC."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to update risk factors and does not contain financial statements or performance metrics.
Material Changes
The filing incorporates by reference an "Updated Risk Factor" (Exhibit 99.1). The text does not specify the nature of the risk update or provide comparative data against prior periods.
Guidance, Outlook, and Risks
The primary purpose of this filing is to disclose an updated risk factor. No management commentary, financial guidance, outlook, or discussion of contingencies is included in the provided text.
Key Facts for Investor Verification
- Verify the specific content of the "Updated Risk Factor" in Exhibit 99.1, as the summary text does not detail the risk.
- Confirm the registrant name is Midatech Pharma PLC, not Biodexa Pharmaceuticals Plc.
- Note that this filing contains no financial data; investors should refer to the most recent Form 20-F for financial performance.